Unknown

Dataset Information

0

Superoxide induced inhibition of death receptor signaling is mediated via induced expression of apoptosis inhibitory protein cFLIP.


ABSTRACT: The death inhibitory proteins, cFLIP and Bcl-2, canonically act at different steps to regulate receptor-mediated apoptosis in cancer cells. Here we report that pharmacological or genetic means to effect an increase in intracellular superoxide result in cFLIP upregulation. Interestingly, Bcl-2 overexpression is associated with a concomitant increase in cFLIP, and reducing superoxide sensitizes Bcl-2 overexpressing cancer cells to receptor-mediated apoptosis via downregulation of cFLIP. Moreover, inhibiting glycolytic flux overcomes apoptosis resistance by superoxide-dependent downregulation of cFLIP. Superoxide-induced upregulation of cFLIP is a function of enhanced transcription, as evidenced by increases in cFLIP promoter activity and mRNA abundance. The positive effect of superoxide on cFLIP is mediated through its reaction with nitric oxide to generate peroxynitrite. Corroborating these findings in cell lines, subjecting primary cells derived from lymphoma patients to glucose deprivation ex vivo, as a means to decrease superoxide, not only reduced cFLIP expression but also significantly enhanced death receptor sensitivity. Based on this novel mechanistic insight into the redox regulation of cancer cell fate, modulation of intracellular superoxide could have potential therapeutic implications in cancers in which these two death inhibitory proteins present a therapeutic challenge.

SUBMITTER: Hirpara JL 

PROVIDER: S-EPMC6965745 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Superoxide induced inhibition of death receptor signaling is mediated via induced expression of apoptosis inhibitory protein cFLIP.

Hirpara Jayshree L JL   Subramaniam Kothandharaman K   Bellot Gregory G   Qu Jianhua J   Seah Serena S   Loh Thomas T   Tucker-Kellogg Lisa L   Clement Marie-Veronique MV   Pervaiz Shazib S  

Redox biology 20191216


The death inhibitory proteins, cFLIP and Bcl-2, canonically act at different steps to regulate receptor-mediated apoptosis in cancer cells. Here we report that pharmacological or genetic means to effect an increase in intracellular superoxide result in cFLIP upregulation. Interestingly, Bcl-2 overexpression is associated with a concomitant increase in cFLIP, and reducing superoxide sensitizes Bcl-2 overexpressing cancer cells to receptor-mediated apoptosis via downregulation of cFLIP. Moreover,  ...[more]

Similar Datasets

| S-EPMC3089506 | biostudies-literature
| S-EPMC5703722 | biostudies-literature
| S-EPMC6043780 | biostudies-literature
| S-EPMC4349737 | biostudies-literature
| S-EPMC6311529 | biostudies-literature
| S-EPMC2612377 | biostudies-literature
| S-EPMC8863773 | biostudies-literature
| S-EPMC7014033 | biostudies-literature
| S-EPMC3562069 | biostudies-literature
| S-EPMC4760830 | biostudies-literature